Rep. April McClain Delaney Sells STERIS plc (NYSE:STE) Shares

Representative April McClain Delaney (D-Maryland) recently sold shares of STERIS plc NYSE: STE. In a filing disclosed on July 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in STERIS stock on June 26th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Paychex NASDAQ: PAYX on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Clean Harbors NYSE: CLH on 6/20/2025.
• Purchased $1,001 - $15,000 in shares of Tractor Supply NASDAQ: TSCO on 6/6/2025.
• Purchased $1,001 - $15,000 in shares of Markel Group NYSE: MKL on 6/6/2025.
• Sold $15,001 - $50,000 in shares of Fortune Brands Innovations NYSE: FBIN on 5/29/2025.
• Sold $1,001 - $15,000 in shares of Toro NYSE: TTC on 5/28/2025.
• Sold $1,001 - $15,000 in shares of Dayforce NYSE: DAY on 5/27/2025.
• Purchased $1,001 - $15,000 in shares of Markel Group NYSE: MKL on 5/27/2025.
• Purchased $1,001 - $15,000 in shares of Tractor Supply NASDAQ: TSCO on 5/27/2025.
• Sold $1,001 - $15,000 in shares of Bio-Techne NASDAQ: TECH on 5/26/2025.

STERIS Price Performance

NYSE STE traded down $3.34 on Thursday, reaching $224.28. The company's stock had a trading volume of 1,076,141 shares, compared to its average volume of 558,339. STERIS plc has a twelve month low of $200.98 and a twelve month high of $252.79. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.39 and a current ratio of 1.96. The stock has a market cap of $22.06 billion, a PE ratio of 36.17 and a beta of 0.92. The firm's 50 day moving average is $238.72 and its two-hundred day moving average is $226.41.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.47 billion. STERIS had a net margin of 11.26% and a return on equity of 14.21%. The firm's revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.58 earnings per share. As a group, sell-side analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th were given a dividend of $0.57 per share. The ex-dividend date of this dividend was Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS's dividend payout ratio is currently 36.77%.

Institutional Trading of STERIS

A number of hedge funds and other institutional investors have recently made changes to their positions in STE. Geneos Wealth Management Inc. increased its stake in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 104 shares during the last quarter. Avalon Trust Co purchased a new stake in STERIS in the 4th quarter worth approximately $30,000. Grove Bank & Trust lifted its holdings in STERIS by 4,733.3% in the 1st quarter. Grove Bank & Trust now owns 145 shares of the medical equipment provider's stock worth $33,000 after buying an additional 142 shares during the period. Zions Bancorporation National Association UT bought a new position in shares of STERIS in the 1st quarter worth approximately $37,000. Finally, ORG Wealth Partners LLC bought a new position in shares of STERIS in the 1st quarter worth approximately $43,000. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

STE has been the subject of several analyst reports. Stephens restated an "overweight" rating and set a $250.00 target price on shares of STERIS in a research report on Thursday, May 15th. Jefferies Financial Group began coverage on STERIS in a report on Thursday, May 29th. They set a "hold" rating and a $263.00 target price on the stock. Wall Street Zen raised STERIS from a "buy" rating to a "strong-buy" rating in a research note on Saturday, June 14th. Citigroup reiterated an "outperform" rating on shares of STERIS in a report on Friday, May 16th. Finally, JMP Securities boosted their price objective on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a research report on Friday, May 16th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $266.50.

Insider Activity at STERIS

In related news, CEO Daniel A. Carestio sold 17,626 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $242.56, for a total transaction of $4,275,362.56. Following the completion of the transaction, the chief executive officer owned 51,385 shares of the company's stock, valued at $12,463,945.60. This trade represents a 25.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Cary L. Majors sold 12,828 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $250.08, for a total value of $3,208,026.24. Following the completion of the transaction, the senior vice president owned 11,372 shares in the company, valued at approximately $2,843,909.76. This trade represents a 53.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by corporate insiders.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.